Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer
about
Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 14 September 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Combined inhibition of MEK and ...... in non-small cell lung cancer
@en
Combined inhibition of MEK and ...... in non-small cell lung cancer
@nl
type
label
Combined inhibition of MEK and ...... in non-small cell lung cancer
@en
Combined inhibition of MEK and ...... in non-small cell lung cancer
@nl
prefLabel
Combined inhibition of MEK and ...... in non-small cell lung cancer
@en
Combined inhibition of MEK and ...... in non-small cell lung cancer
@nl
P2093
P2860
P50
P356
P1433
P1476
Combined inhibition of MEK and ...... in non-small cell lung cancer
@en
P2093
Eisuke Kurihara
Hidejiro Torigoe
Hiroki Sato
Hirokuni Ikeda
Kazuhiko Shien
Masakiyo Sakaguchi
Minami Hatono
Shuta Tomida
Tadahiko Shien
P2860
P304
P356
10.1111/CAS.13763
P407
P577
2018-09-14T00:00:00Z